| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/18/2005 | CA2554353A1 Treatment of neurodegenerative diseases by the use of gpr49 |
| 08/18/2005 | CA2553679A1 Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration |
| 08/18/2005 | CA2552999A1 Identification of novel ige epitopes |
| 08/18/2005 | CA2552458A1 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| 08/18/2005 | CA2548210A1 Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods |
| 08/17/2005 | EP1564286A1 Hybrid proteins of beta-lactamase class A |
| 08/17/2005 | EP1563309A2 Use of nuclear hormone receptors to identify meiosis regulating compounds |
| 08/17/2005 | EP1563308A2 Methods and kits for diagnosing tumorigenicity |
| 08/17/2005 | EP1563301A2 Method for the prevention of malaria |
| 08/17/2005 | EP1563056A2 Composition and method for treating lupus nephritis |
| 08/17/2005 | EP1562986A2 Compounds and methods for modulating functions of classical cadherins |
| 08/17/2005 | EP1562983A2 Multiple variants of meningococcal protein nmb1870 |
| 08/17/2005 | EP1562977A2 Active specific immunotherapy of cancer metastasis |
| 08/17/2005 | EP1562969A2 Novel human cell surface protein with immunoglobulin folds, bgs-19 |
| 08/17/2005 | EP1562968A1 Anti-il-6 antibodies, compositions, methods and uses |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562622A2 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP1562571A1 Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance |
| 08/17/2005 | EP1407006B1 Method for the recovery and purification of poxviruses from infected cells |
| 08/17/2005 | EP1285271B1 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 08/17/2005 | EP1248643B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 08/17/2005 | EP1224215B1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1109908B1 Methods for determining compounds for modulating the body weight |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP1003478B1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 08/17/2005 | EP0975674B1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0833917B1 Malarial pre-erythrocytic stage polypeptide molecules |
| 08/17/2005 | EP0760671B1 Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| 08/17/2005 | EP0636172B1 Genetically engineered attenuated viruses |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656120A Immunological binding molecules inhibiting the syncytial fusion of trophoblast |
| 08/17/2005 | CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus |
| 08/17/2005 | CN1655845A Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 08/17/2005 | CN1655825A Non-viral gene delivery system |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655813A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 08/17/2005 | CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease |
| 08/17/2005 | CN1654666A Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 08/17/2005 | CN1654665A Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 08/17/2005 | CN1654661A Construction and expression of recombinant human trypsinogen 2 expression vector, preparation and application of its monoclonal antibody |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654639A Recombinant asparaginase with function of preventing and curing diabetes mellitus |
| 08/17/2005 | CN1654475A Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 08/17/2005 | CN1654474A 重组幽门螺杆菌热休克蛋白60 Recombinant H. pylori heat shock protein 60 |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1654472A Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/17/2005 | CN1654471A Recombinant helicobacter pylori blood group antigen adhesin |
| 08/17/2005 | CN1654470A Recombinant helicobacter pylori outer-membrane protein 15 |
| 08/17/2005 | CN1654072A Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 08/17/2005 | CN1215167C Helicobacter pylori live vaccine |
| 08/17/2005 | CN1215083C Monoclonal antibody for resisting human liver cancer and its application |
| 08/17/2005 | CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| 08/17/2005 | CN1214781C Hybrid matrices and hybrid matrix mixtures |
| 08/16/2005 | US6930181 a neuroendocrine protein antigen associated with Type I diabetes mellitus, nucleic acid encoding the protein and methods and reagents for detecting antibody against the protein and identifying individuals at risk of developing Type I diabetes |
| 08/16/2005 | US6930176 Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
| 08/16/2005 | US6930167 DNA encoding bovine immunoglobulin a inducing protein and uses therefor |
| 08/16/2005 | US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
| 08/16/2005 | US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections |
| 08/16/2005 | US6929799 Live-attenuated mycobacterium containing a D-alanine racemase mutant of a pathogenic species which displays increased susceptibility to an antimycobacterial agent such as D-cycloserine and alanine derivatives |
| 08/16/2005 | US6929796 Methods to treat undesirable immune responses |
| 08/16/2005 | US6929795 Contacting a sample from the blood of a human or animal with the chimeric polypeptide and determining the presence of visceral Leishmaniosis by detection of binding between polypeptide and Leishmania infantum antibodies |
| 08/16/2005 | US6929794 IL-12 as an adjuvant for Bordetella pertussis vaccines |
| 08/16/2005 | CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 08/16/2005 | CA2157500C Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/11/2005 | WO2005073387A2 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 08/11/2005 | WO2005073248A1 Peptides for treatment of autoimmune diseases |
| 08/11/2005 | WO2005072777A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 08/11/2005 | WO2005072772A1 Pharmaceutical compositions |
| 08/11/2005 | WO2005072479A2 Polymer-bound antibody concer therapeutic agent |
| 08/11/2005 | WO2005072241A2 Inhibition of bright function as a treatment for excessive immunoglobulin production |
| 08/11/2005 | WO2005072214A2 Improved inactivated fcv vaccines |
| 08/11/2005 | WO2005072126A2 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 08/11/2005 | WO2005072088A2 Immunotherapy compositions, method of making and method of use thereof |
| 08/11/2005 | WO2005066204A3 Neutralizing epitope-based growth enhancing vaccine |
| 08/11/2005 | WO2005049647A3 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 08/11/2005 | WO2005044854A3 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 08/11/2005 | WO2005041877A9 Method of inhibiting rejection following organ transplantation |
| 08/11/2005 | WO2005002501A3 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 08/11/2005 | WO2005001053A3 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 08/11/2005 | WO2005000899A3 Modified binding molecules comprising connecting peptides |
| 08/11/2005 | WO2004103312A3 Peptides useful as hiv fusion inhibitors |
| 08/11/2005 | WO2004101607A3 Comparative ligand mapping from mhc class i positive cells |
| 08/11/2005 | WO2004070025A3 Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 08/11/2005 | WO2004030522A3 Diagnosis and monitoring of diseases |
| 08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 08/11/2005 | US20050176947 Optical recording apparatus using one-dimensional diffractive light modulator |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176942 Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
| 08/11/2005 | US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176929 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 08/11/2005 | US20050176672 Use of cationic lipids to generate anti-tumor immunity |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus |